Key Quantitative Figures

  • Total number of options granted: 35,59,000 (Thirty Five Lakh Fifty Nine Thousand Only)
  • Each option exercisable into: 1 equity share
  • Total potential equity shares: 35,59,000 equity shares
  • Face value of each share: ₹2
  • Exercise price per option: ₹200

Parties Involved

  • Nomination and Remuneration Committee (approving authority)
  • Kashish Arora, Company Secretary and Compliance Officer (signatory)
  • National Stock Exchange of India Ltd
  • BSE Limited

Terms and Conditions

  • Vesting period: Minimum 3 years from date of grant
  • Exercise period: Maximum 5 years from date of vesting
  • Vesting schedule: As specified in the Grant Letter

Additional Information

  • The scheme complies with Securities and Exchange Board of India (Share Based Employee Benefits & Sweat Equity) Regulations, 2021
  • No options have been vested, exercised, lapsed, or varied as of this disclosure
  • No money has been realized from exercise of options
  • No diluted earnings per share calculation provided
  • The information is available on the company's website at www.crizac.com

Financial Impact

Potential equity dilution of 35,59,000 shares upon full exercise of all options. The financial impact of the ESOP grant on employee compensation expense is not quantified in the disclosure.